TAKEDA
LIVE

Add to watchlist:

No watchlists yet
View on USPTO

TAKEDA Trademark

Serial Number: 98035470

TAKEDA is a trademark filed by Takeda Pharmaceutical Company Limited on June 9, 2023. The trademark is classified under Class 9 (Computers & Electronics), Class 41 (Education & Entertainment), Class 42 (Computer & Scientific), Class 35 (Advertising & Business). The application is currently pending registration.

Owner Contact Info

Takeda Pharmaceutical Company Limited

1-1, Doshomachi 4-chome, Chuo-ku
Osaka 541-0045 , JP

Entity Type: 99

Trademark Details

Filing Date

June 9, 2023

Registration Date

Not Registered

Published for Opposition

May 6, 2025

Goods & Services

Downloadable virtual goods, namely, computer programs featuring pharmaceutical preparations for treating or diagnosing disorders, diseases, and rare diseases, medical devices used for administering pharmaceutical preparations, medical devices for reconstituting pharmaceutical preparations, medical devices for reconstituting and administering pharmaceutical preparations, and pharmaceutical preparations and medical devices associated with health care and medical services, namely, pharmaceutical patient support program, healthcare provider support program, and medical professional support program providing health and medical information in the field of pharmaceutical products and services, with all of the aforementioned goods in the field of autoimmunology, bacterial infection diseases and disorders, cardiology, central and peripheral nervous systems diseases and disorders, diabetes, endocrinology, hematology, hormonal diseases and disorders, gastroenterology, gout, immunology, infectious diseases and disorders, inflammatory diseases and disorders, musculoskeletal diseases and disorders, neuroscience, oncology, pain management, respiratory diseases and disorders, genetic diseases and disorders, urological diseases and disorders, kidney diseases and disorders, viral diseases and disorders, for use in online virtual environments, augmented reality, extended reality, and mixed reality environments; Downloadable digital image files of pharmaceutical preparations for treating or diagnosing disorders, diseases, and rare diseases, medical devices used for administering pharmaceutical preparations, medical devices for reconstituting pharmaceutical preparations, medical devices for reconstituting and administering pharmaceutical preparations, and pharmaceutical preparations and medical devices associated with health care and medical services, namely, pharmaceutical patient support program, healthcare provider support program, and medical professional support program providing health and medical information in the field of pharmaceutical products and services, with all of the aforementioned goods in the field of autoimmunology, bacterial infection diseases and disorders, cardiology, central and peripheral nervous systems diseases and disorders, diabetes, endocrinology, hematology, hormonal diseases and disorders, gastroenterology, gout, immunology, infectious diseases and disorders, inflammatory diseases and disorders, musculoskeletal diseases and disorders, neuroscience, oncology, pain management, respiratory diseases and disorders, genetic diseases and disorders, urological diseases and disorders, kidney diseases and disorders, viral diseases and disorders authenticated by non-fungible tokens (NFTs); Downloadable computer software for providing access to online virtual environments, augmented reality, extended reality, and mixed reality environments related to pharmaceutical preparations, medical devices, health care and medical services; Downloadable computer software for providing access to online virtual environments, augmented reality, extended reality, and mixed reality environments related to educational services in the field of pharmaceuticals, medicines, health care and medical services; Downloadable computer software for providing access to games in online virtual environments, augmented reality, extended reality, and mixed reality environments; Downloadable computer software for providing access to video games

Providing online retail store services featuring virtual or mixed reality software that displays virtual goods and enables customers to purchase and store virtual goods and services related to pharmaceutical preparations, medical devices, health care and medical services for use in online virtual environments, augmented reality, extended reality, and mixed reality; Providing online marketplace services featuring virtual or mixed reality software that displays virtual goods and enables customers to purchase and store virtual goods and services for buyers and sellers of virtual goods related to pharmaceutical preparations, medical devices, health care and medical services for use in online virtual environments, augmented reality, extended reality, and mixed reality environments

Entertainment services, namely, providing online, non-downloadable virtual goods, in particular, pharmaceutical preparations for treating or diagnosing disorders, diseases, and rare diseases, medical devices used for administering pharmaceutical preparations, medical devices for reconstituting pharmaceutical preparations, medical devices for reconstituting and administering pharmaceutical preparations, and pharmaceutical preparations and medical devices associated with health care and medical services, namely, pharmaceutical patient support program, healthcare provider support program, and medical professional support program providing health and medical information in the field of pharmaceutical products and services, with all of the aforementioned goods in the field of autoimmunology, bacterial infection diseases and disorders, cardiology, central and peripheral nervous systems diseases and disorders, diabetes, endocrinology, hematology, hormonal diseases and disorders, gastroenterology, gout, immunology, infectious diseases and disorders, inflammatory diseases and disorders, musculoskeletal diseases and disorders, neuroscience, oncology, pain management, respiratory diseases and disorders, genetic diseases and disorders, urological diseases and disorders, kidney diseases and disorders, viral diseases and disorders for use in online virtual environments, augmented reality, extended reality, and mixed reality environments created for entertainment purposes; Entertainment services, namely, providing online, non-downloadable virtual environments, augmented reality, extended reality, and mixed reality environment video games in which users can interact for recreational, leisure, or entertainment purposes; Entertainment services, namely, providing online, non-downloadable video games; Entertainment services, namely, providing online virtual environments, augmented reality, extended reality, and mixed reality environments in which users can interact for recreational purposes

Providing temporary use of non-downloadable computer software for the purchase and transfer of digital media, namely, digital assets, digital collectibles, digital tokens and non-fungible tokens (NFTs) for virtual goods related to pharmaceutical preparations for treating or diagnosing disorders, diseases, and rare diseases, medical devices used for administering pharmaceutical preparations, medical devices for reconstituting pharmaceutical preparations, medical devices for reconstituting and administering pharmaceutical preparations, and pharmaceutical preparations and medical devices associated with health care and medical services, namely, pharmaceutical patient support program, healthcare provider support program, and medical professional support program providing health and medical information in the field of pharmaceutical products and services, with all of the aforementioned goods in the field of autoimmunology, bacterial infection diseases and disorders, cardiology, central and peripheral nervous systems diseases and disorders, diabetes, endocrinology, hematology, hormonal diseases and disorders, gastroenterology, gout, immunology, infectious diseases and disorders, inflammatory diseases and disorders, musculoskeletal diseases and disorders, neuroscience, oncology, pain management, respiratory diseases and disorders, genetic diseases and disorders, urological diseases and disorders, kidney diseases and disorders, viral diseases and disorders for use in online virtual environments, augmented reality, extended reality, and mixed reality environments; Providing temporary use of non-downloadable computer software for providing access to online virtual environments, augmented reality, extended reality, and mixed reality environments related to pharmaceutical preparations, medical devices, health care and medical services; Providing temporary use of non-downloadable computer software for providing access to online virtual environments, augmented reality, extended reality, and mixed reality environments related to educational services in the field of medicines, pharmaceuticals, health care and medical services

Filing History

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Apr 11, 2026 EXRA
SOU EXTENSION 2 GRANTED
Apr 10, 2026 EX2G
SOU EXTENSION 2 FILED
Apr 10, 2026 EXT2
SOU TEAS EXTENSION RECEIVED
Apr 10, 2026 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Nov 14, 2025 EXRA
SOU EXTENSION 1 GRANTED
Nov 13, 2025 EX1G
SOU EXTENSION 1 FILED
Nov 13, 2025 EXT1
SOU TEAS EXTENSION RECEIVED
Nov 13, 2025 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jul 1, 2025 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 6, 2025 NPUB
PUBLISHED FOR OPPOSITION
May 6, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 30, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 8, 2025 CNSA
EXAMINER'S AMENDMENT ENTERED
Apr 8, 2025 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Apr 8, 2025 GNEN
EXAMINERS AMENDMENT E-MAILED
Apr 8, 2025 GNEA
EXAMINERS AMENDMENT -WRITTEN
Apr 8, 2025 CNEA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jan 28, 2025 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Jan 28, 2025 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jan 28, 2025 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jan 28, 2025 REAP
NOTIFICATION OF FINAL REFUSAL EMAILED
Jan 27, 2025 GNFN
FINAL REFUSAL E-MAILED
Jan 27, 2025 GNFR
FINAL REFUSAL WRITTEN
Jan 27, 2025 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 4, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 4, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Oct 4, 2024 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jul 9, 2024 GNRN
NON-FINAL ACTION E-MAILED
Jul 9, 2024 GNRT
NON-FINAL ACTION WRITTEN
Jul 9, 2024 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
May 16, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 16, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 16, 2024 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Mar 4, 2024 GNRN
NON-FINAL ACTION E-MAILED
Mar 4, 2024 GNRT
NON-FINAL ACTION WRITTEN
Mar 4, 2024 CNRT
ASSIGNED TO EXAMINER
Feb 29, 2024 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 13, 2023 NWOS
NEW APPLICATION ENTERED
Jun 13, 2023 NWAP